Medicinal Products
Androcur 50 mg tablete
| Name |
Androcur 50 mg tablete |
| Marketing Authorisation Number |
HR-H-843981106 |
| Active Substance |
ciproteronacetat |
| Composition |
jedna tableta sadrži 50 mg ciproteronacetata |
| Pharmaceutical Form |
tableta |
| Manufacturer |
Bayer Weimar GmbH und Co. KG., Weimar, Njemačka |
| Marketing Authorisation Holder |
Advanz Pharma Limited, Unit 17, Northwood House, Northwood Crescent, Dublin 9, Irska |
| Marketing Authorisation Date |
26.05.2025 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/15-02/04 |
| Registration Number |
381-12-01/171-25-39 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
G03HA01 |
| Marketing status |
Marketed |
| Shortage status |
Actual |
| SmPC |
download |
| PL |
download |
Packaging
| Packaging description |
MA Number for Packaging |
Marketing status |
Shortage status |
| 50 tableta u blisteru, u kutiji |
HR-H-843981106-01 |
Marketed |
Actual |
Direct Healthcare Professional Communication
| Name |
Date |
Download |
| Pismo zdravstvenim radnicima o ograničenjima primjene lijeka Androcur 50 mg tablete (ciproteronacetat) zbog rizika od meningeoma |
16.04.2020 |
Bayer d.o.o. |
Back
